Introduction Xanax also known by its generic name alprazolam is one of the most widely prescribed medications in the world and in 2026 it remains one of the most important and widely used treatments for anxiety disorders, panic disorder and anxiety associated with depression. It belongs to the benzodiazepine class of drugs and works by […]

Introduction The emergence of ketamine as a revolutionary treatment for depression has given rise to two primary treatment approaches that are now widely used by psychiatrists and mental health professionals across the world. These two approaches are esketamine nasal spray and intravenous ketamine infusion. Both have demonstrated remarkable and well documented effectiveness for treatment resistant

Introduction The demand for ketamine has grown exponentially over the past several years driven by the remarkable and well documented success of ketamine therapy for treatment resistant depression, PTSD, chronic pain and other serious medical conditions. As we move through 2026 more patients, researchers and medical professionals than ever are seeking access to pharmaceutical grade

Introduction Anxiety disorders are among the most common mental health conditions in the world affecting hundreds of millions of people globally. When it comes to pharmaceutical treatment of anxiety disorders and panic attacks two of the most widely prescribed and recognized medications are Xanax and Diazepam. Both belong to the benzodiazepine class of medications and

Introduction Depression is one of the most devastating and widespread mental health conditions affecting humanity today. According to the World Health Organization more than 280 million people worldwide suffer from depression making it the leading cause of disability globally. For decades the standard treatment options have been limited to antidepressant medications like SSRIs and SNRIs